Sign In
Buy PJT
$154.84
-1.94 (-1.24%)
At Close: Jun 03, 2026
Analysts Estimate PJT Partners (PJT) to Report a Decline in Earnings: What to Look Out for
02:01pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
PJT Partners (PJT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PJT Partners Inc. to Report Second Quarter 2022 Financial Results and Host a Conference Call on July 26, 2022
06:01pm, Monday, 18'th Jul 2022
NEW YORK--(BUSINESS WIRE)--PJT Partners Inc. (“PJT Partners”) (NYSE:PJT) announced that it expects to release its second quarter 2022 financial results on Tuesday morning, July 26, 2022. The earni
Where PJT Partners Stands With Analysts
01:09pm, Monday, 06'th Jun 2022 Benzinga
Within the last quarter, PJT Partners (NYSE:PJT) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
6
0
0
0
Last 30D
0
PJT Partners: Seeing Growth In Advisory, Restructuring Growth Still To Come
08:00am, Tuesday, 17'th May 2022
The company is seeing revenue growth, but not in restructuring yet which is the catalyst for our thesis. Nonetheless, an advisory business that is performing well while advisory activity across market
PJT Partners Inc. (PJT) CEO Paul Taubman on Q1 2022 Results - Earnings Call Transcript
01:40pm, Tuesday, 26'th Apr 2022
Start Time: 08:30 January 1, 0000 9:18 AM ET PJT Partners Inc. (NYSE:PJT ) Q1 2022 Earnings Conference Call April 26, 2022, 08:30 AM ET Company Participants Paul Taubman - Chairman and CEO Helen Meate
Rotten Revisions: Stocks To Avoid With EPS Downward Revisions
12:30pm, Tuesday, 26'th Apr 2022 Seeking Alpha
Earnings revisions are a key metric that shouldn't be ignored when it comes to picking stocks. Click here to learn about the biggest stock losers (stocks with down revisions) this season.
PJT Partners (PJT) Surpasses Q1 Earnings and Revenue Estimates
12:05pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
PJT Partners (PJT) delivered earnings and revenue surprises of 21.95% and 16.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
PJT Partners (PJT) Surpasses Q1 Earnings and Revenue Estimates
09:47am, Tuesday, 26'th Apr 2022
PJT Partners (PJT) delivered earnings and revenue surprises of 21.95% and 16.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: PJT Partners (PJT) Q1 Earnings Expected to Decline
07:01pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
PJT Partners (PJT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PJT Partners Inc. to Report First Quarter 2022 Financial Results and Host a Conference Call on April 26, 2022
06:23pm, Tuesday, 19'th Apr 2022
NEW YORK--(BUSINESS WIRE)--PJT Partners Inc. (“PJT Partners”) (NYSE:PJT) announced that it expects to release its first quarter 2022 financial results on Tuesday morning, April 26, 2022. The earni
Earnings Preview: PJT Partners (PJT) Q1 Earnings Expected to Decline
04:33pm, Tuesday, 19'th Apr 2022
PJT Partners (PJT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022
02:07pm, Thursday, 07'th Apr 2022 Benzinga
Upgrades
According to Wolfe Research, the prior rating for Cullen/Frost Bankers Inc (NYSE:CFR) was changed from Underperform to Outperform. For the fourth quarter, Cullen/Frost Bankers had an EPS of $
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
02:16pm, Wednesday, 06'th Apr 2022 Benzinga
Upgrades
According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c
